Developing drugs for the ‘undruggable’
There are up to 650,000 ‘undruggable’ protein-protein interactions (PPIs) in the human interactome that can be potentially considered as novel therapeutic targets. How does the ‘undruggable’ become ‘druggable’?
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-10-01
|
Series: | BioTechniques |
Online Access: | https://www.future-science.com/doi/10.2144/btn-2020-0134 |